The abstract is read at the publisher; the summary is JClub's.
Lactate increases hypoxia pathway activity in a HIF1α-dependent manner, with KAT5 driving HIF1α lactylation at K389, K460, K674, and K682.
- Why it matters: The tumor microenvironment’s lactate and lactylation effects on hypoxia signaling are unclear, limiting how hypoxic progression and therapy resistance might be targeted.
- What they did: The study mapped KAT5 as a lysine lactyltransferase and HDAC2 as a HIF1α de-lactylase, then tested a lactylation-deficient HIF1α 4KR mutant and the KAT5 inhibitor MG149 in a murine model.
- The result: HIF1α 4KR reduced HIF1α stability and down-regulated hypoxia-mediated angiogenesis, metastasis, apoptosis, and glycolysis, while MG149 suppressed tumor hypoxia signaling and enhanced anti-PD-1 combination immunotherapy efficacy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.